Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$542.50 -6.54 (-1.19%)
At close: Nov 5, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Acquisitions (2009 - 2019)

Updated

Vertex Pharmaceuticals (VRTX) reported Acquisitions of $295.9 million for FY2022.

Analysis

Vertex Pharmaceuticals (VRTX) Acquisitions (2009 - 2019) Analysis & Trends

  • Acquisitions has a three-year compound annual growth rate of -36.5% (FY2019 to FY2022).
  • The FY2022 figure ranks as the highest annual Acquisitions since FY2019.
  • According to Business Quant data, Acquisitions came in at $1.15 billion in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn -17.15 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn 10.59 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn -
5 Novartis Ag 313.89 Bn 287.12 Bn - -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn -
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn -
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn 19.00 Mn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 137.20 Bn 109.19 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 908.38 Mn
Mar 31, 2009 87.42 Mn
API Access

Vertex Pharmaceuticals Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=VRTX&period=max&api_key=YOUR_API_KEY